white
matter
diseas
afflict
develop
matur
central
nervou
system
cell
intrins
extrins
dysregul
result
profound
chang
cell
surviv
axon
metabol
function
perform
experiment
model
development
white
matter
wm
injuri
demyelin
delin
mechan
signal
inflamm
also
pave
way
discoveri
pharmacolog
approach
intervent
reagent
shown
enhanc
protect
matur
oligodendrocyt
cell
acceler
progenitor
cell
recruit
andor
differenti
attenu
patholog
stimuli
aris
inflammatori
respons
injuri
highlight
report
studi
cn
compound
name
peptid
hormon
small
molecul
agonistsantagonist
use
experiment
anim
model
demyelin
neonat
brain
injuri
affect
aspect
excitotox
oligodendrocyt
develop
surviv
progenitor
cell
function
demonstr
attenu
damag
improv
wm
protect
experiment
model
injuri
molecular
target
agent
includ
growth
factor
neurotransmitt
receptor
morphogen
signal
compon
nuclear
receptor
well
process
iron
transport
actin
bind
survey
current
evid
nonimmun
target
immatur
matur
wm
aim
better
understand
pharmacolog
approach
modul
endogen
oligodendroglia
show
potenti
success
context
development
adult
wm
patholog
abbrevi
central
nervou
system
wm
white
matter
opc
oligodendrocyt
progenitor
cell
ol
oligodendrocyt
svz
subventricular
zone
eae
experiment
autoimmun
enceph
bromodeoxyuridin
chew
deboy
oligodendrocyt
essenti
role
function
healthi
nervou
system
howev
also
among
vulner
neural
cell
type
cn
result
central
myelin
abnorm
found
wide
varieti
neurolog
disord
white
matter
patholog
found
mani
neurolog
diseas
includ
genet
leukodystrophi
costello
et
al
brain
injuri
kinnunen
et
al
endocrin
metabol
abnorm
siever
et
al
van
der
werff
et
al
psychiatr
ladouceur
et
al
neurodegen
condit
mascalchi
heterogen
patholog
rang
abnorm
myelin
structur
virtual
absenc
myelin
aris
directli
lack
myelin
product
indirectli
damag
myelin
white
matter
patholog
insult
oxid
stress
mechan
injuri
inflamm
ultim
lead
degen
loss
myelin
demyelin
inadequ
abnorm
format
myelin
hypomyelinationdysmyelin
primari
mechan
myelin
damag
includ
destruct
myelin
sheath
oligodendrocyt
ol
death
merril
scold
failur
progenitor
cell
recruit
andor
differenti
remyelin
kremer
et
al
shi
et
al
case
neonat
delay
opc
matur
defect
ensheath
myelin
axon
jablonska
et
al
ritter
et
al
scafidi
et
al
wm
support
multipl
axon
function
besid
saltatori
conduct
wm
injuri
invari
lead
associ
devast
neurolog
disabl
includ
motor
cognit
impair
adult
cn
approach
intervent
protect
demyelin
includ
attenu
immunemedi
excitotox
oxid
stressmedi
damag
well
cell
engraft
direct
protect
endogen
ol
enhanc
repair
oligodendrocyt
progenitor
cell
opc
success
cell
replac
therapi
dictat
lesion
environ
blakemor
et
al
understand
multitud
factor
remyelin
failur
need
success
graft
also
stimul
repair
endogen
progenitor
cell
develop
brain
perinat
wm
damag
current
cure
constitut
import
compon
injuri
cerebrum
includ
neuron
axon
mani
insult
occur
utero
consequ
preterm
birth
complic
deliveri
silberei
et
al
improv
antenat
care
incid
tissu
degener
cystic
lesion
wm
declin
wherea
predomin
lesion
becom
diffus
silberei
et
al
adult
mechan
result
injuri
may
also
excitotox
inflammatori
oxid
van
steenwinckel
et
al
may
either
impact
ol
directli
synaps
axon
shen
et
al
cell
microglia
kaur
et
al
astrocyt
connect
interestingli
white
matter
integr
connect
impact
condit
besid
primari
demyelin
diseas
psychiatr
neurodegen
disord
mascalchi
sinc
antipsychot
antidepress
therapi
found
addit
attenu
myelin
damag
target
approach
promot
preserv
myelin
wide
varieti
neurolog
condit
would
justifi
bartzoki
mani
neurolog
diseas
strongli
associ
inflamm
surprisingli
therapeut
reagent
found
protect
ol
cell
damag
shown
possess
immunomodulatori
properti
howev
continu
oligodendrogenesi
consid
central
compon
brain
plastic
remodel
throughout
life
young
et
al
chosen
emphasi
nonimmun
therapeut
target
employ
improv
myelin
remyelin
endogen
opc
review
report
pharmacolog
intervent
experiment
model
demyelin
hypomyelinationdysmyelin
hope
identifi
overlap
mechan
show
potenti
benefit
neonat
adult
wm
patholog
experiment
model
adult
wm
damag
involv
viral
chemic
immunemedi
demyelin
paradigm
well
spinal
cord
injuri
system
well
describ
laboratori
rodent
tanaka
yoshida
briefli
gliotox
chemic
inject
wm
gener
local
lesion
includ
ethidium
bromid
kill
ol
intercal
minor
groov
dna
lysolecithinlysophosphatidylcholin
hall
specif
disrupt
myelin
sheath
cuprizon
biscyclohexanoneoxaldihydrazon
copper
chelat
caus
ol
apoptosi
impair
metabol
function
inhibit
cellular
support
myelin
administ
via
diet
caus
diffus
demyelin
notabl
restrict
skripuletz
et
al
wm
region
matsushima
morel
remyelin
initi
resum
cuprizonefre
diet
week
none
toxinbas
method
demyelin
mimic
dynam
pathogenesi
human
diseas
use
understand
mani
aspect
damag
remyelin
preferenti
vulner
myelin
without
signific
axon
loss
properti
cellular
respons
recoveri
biolog
factor
regul
process
therapeut
regimen
improv
cellular
repair
focal
lesion
provid
rapid
demyelin
circumscrib
secondari
inflamm
hall
miron
et
al
direct
progenitor
recruit
may
studi
use
lesion
endpoint
destin
jablonska
et
al
addit
unilater
lesion
allow
intern
control
sampl
aguirr
et
al
howev
practic
consider
consist
lesion
size
locat
applic
quantit
analysi
histolog
biochem
method
add
technic
demand
approach
model
valuabl
studi
cellular
respons
remyelin
myelin
loss
injuri
lack
autoimmun
compon
ms
consid
ideal
anim
model
ms
interest
reader
refer
comprehens
chapter
articl
discuss
ms
model
croxford
et
al
merril
ransohoff
diffus
demyelin
also
observ
immunemedi
model
experiment
autoimmun
enceph
eae
eae
remain
influenti
understand
inflammatori
demyelin
robinson
et
al
eae
may
produc
mice
rat
gener
passiv
immun
wm
tissu
homogen
immun
mbp
mog
third
method
adopt
transfer
cell
isol
myelin
peptid
prime
anim
allow
select
vitro
manipul
cell
transfer
naiv
recipi
produc
eae
robinson
et
al
anoth
inflammatori
model
demyelin
util
virusestheil
murin
encephalomyel
viru
tmev
neurotroph
variant
mous
hepat
viru
mhv
stimul
activ
cell
induc
chronic
demyelin
lane
buchmeier
templeton
perlman
immun
mediat
secret
cell
macrophagesmicroglia
suggest
contribut
virallyinduc
demyelin
due
dysregul
death
oligodendrocyt
lineag
cell
marro
et
al
model
often
consid
alongsid
autoimmunebas
model
eae
use
character
infecti
event
lead
cn
immun
respons
baker
amor
fazakerley
walker
although
eae
power
remain
commonli
use
ms
model
recogn
limit
ms
therapi
constantinescu
et
al
stem
depend
artifici
induct
immun
respons
mecha
et
al
unreli
predict
treatment
spinal
cord
prefer
brain
lesion
difficulti
analyz
remyelin
stochast
lesion
inconsist
clinic
function
progress
ransohoff
hand
propon
viral
model
demyelin
note
insideout
axonfirst
degener
presenc
brain
demyelin
progress
diseas
viral
spread
mecha
et
al
given
heterogen
diseas
still
use
continu
identifi
diseasemodifi
treatment
ms
demyelin
model
spinal
cord
contus
injuri
well
traumat
brain
injuri
associ
demyelin
chao
et
al
mcdonald
belegu
similarli
demyelin
also
observ
secondari
hypoxicischem
damag
stroke
model
mifsud
et
al
skoff
et
al
neonat
wm
particularli
vulner
damag
oxid
stressand
inflammationmedi
brain
injuri
neurodevelopment
diseas
preterm
infant
silberei
et
al
cerebr
white
matter
injuri
major
form
brain
injuri
found
survivor
prematur
birth
volp
place
survivor
high
risk
longterm
neurolog
deficit
hack
et
al
wilsoncostello
et
al
experiment
white
matter
lesion
reproduc
develop
brain
use
ventricular
hemorrhag
chua
et
al
ment
et
al
ment
et
al
vose
et
al
prenat
infect
inflamm
review
neonat
hypoxiaischemia
chronic
hypoxia
review
scafidi
et
al
perinat
hypoxicischemia
chronic
hypoxia
rodent
model
may
distinct
mechan
busl
greer
togeth
mimic
mani
aspect
pathogenesi
brain
found
prematur
infant
includ
apoptosi
neuron
glial
progenitor
inflammatori
respons
scafidi
et
al
oligodendrocyt
vulner
glia
ischemia
cultur
mimick
glucoseoxygen
depriv
lyon
kettenmann
vivo
oligodendrocyt
vulner
neuron
ischemia
pantoni
et
al
mediat
injuri
fragoso
et
al
addit
excitotox
import
factor
back
rosenberg
death
preolstag
cell
vivo
hypoxiaischemia
lead
inabl
lineag
progress
matur
back
et
al
studi
experiment
therapeut
variou
perinat
anim
model
use
test
effect
growth
factor
amelior
wm
damag
express
chang
sever
growth
factor
includ
bfgf
egf
igf
bdnf
detect
hypox
rodent
model
dieni
ree
scafidi
et
al
sever
therapeut
strategi
includ
administr
growth
factor
spontan
repair
demyelin
diseas
occur
via
reactiv
process
ol
develop
neural
stem
cell
subventricular
region
brain
svz
give
rise
ol
progenitor
cell
opc
opc
mark
antigen
pdgfra
express
prolifer
migrat
lesion
differenti
premyelin
ol
matur
myelin
ol
elabor
process
express
nucleotid
cnp
proteolipid
protein
plp
myelin
basic
protein
mbp
myelin
associ
glycoprotein
mag
express
transcript
factor
extend
opc
myelin
ol
allow
immunohistochem
analysi
overal
chang
oligodendrogli
lineag
cours
injuri
repair
rodent
spontan
remyelin
highli
robust
effici
proceed
virtual
complet
week
armstrong
et
al
blakemor
ludwin
experiment
model
use
test
pharmacolog
agent
potenti
inhibit
enhanc
myelin
repair
human
diseas
inhibit
abort
abnorm
develop
opc
cerebr
palsi
back
miller
multipl
sclerosi
kipp
et
al
kuhlmann
et
al
believ
contribut
failur
repair
progress
patholog
pharmaceut
protect
ol
death
initi
identifi
immunomodulatori
neuroprotect
properti
although
mani
brain
patholog
benefit
immunomodul
complet
inhibit
immun
activ
detriment
particularli
neonat
mani
aspect
cytokin
function
inextric
associ
growth
properti
progenitor
cell
synergi
immun
cell
adult
neural
stemprogenitor
cell
shown
promot
function
recoveri
spinal
cord
injuri
ziv
et
al
antenat
administr
steroid
glucocorticoid
dexamethason
protect
respiratori
function
anoth
case
point
see
studi
shown
genet
ablat
proinflammatori
cytokin
interleukin
beta
affect
sever
cuprizoneinduc
demyelin
adult
wm
instead
led
inadequ
remyelin
mason
et
al
unexpect
function
express
arnett
et
al
mason
et
al
interferongamma
also
possess
normal
physiolog
function
support
growth
neural
progenitor
cell
li
et
al
immun
modul
alon
current
approach
mani
drug
multipl
sclerosi
initi
suffer
lack
specif
improv
sinc
achiev
increas
abil
specif
target
patholog
compon
adapt
respons
effort
increas
immun
toler
autoimmun
epitop
gett
et
al
studi
eae
also
shown
autoimmun
toler
complet
effect
inhibit
diseas
progress
pryce
et
al
support
therapeut
strategi
combinatori
treatment
multipl
sclerosi
target
immun
compon
alon
reagent
minocyclin
ethyl
pyruv
wang
et
al
even
caffein
adenosin
receptor
modul
shown
protect
lipopolysaccharideand
hyperoxia
schmitz
et
al
induc
perinat
wm
injuri
mani
antiinflammatori
agent
effect
perinat
brain
review
ofekshlomai
ofekshlomai
berger
also
effect
inflamm
associ
adult
traumat
brain
injuri
abdel
baki
et
al
moro
sutton
tissu
damag
lipopolysaccharid
brother
et
al
agent
attenu
cell
death
loss
ol
accompani
suppress
inflammatori
respons
howev
minocyclin
found
reduc
remyelin
cuprizon
demyelin
paradigm
tanaka
et
al
microglialderiv
ciliari
neurotroph
factor
cntf
promot
remyelin
also
suppress
exemplifi
need
caution
antiinflammatori
approach
nitric
oxid
import
regul
cerebr
blood
flow
toda
et
al
inflamm
blomgren
hagberg
inhal
nitric
oxid
consid
therapeut
target
neonat
brain
injuri
charriautmarlangu
et
al
although
shown
effect
directli
promot
cellular
regener
benefici
effect
neurolog
outcom
prematur
infant
report
mestan
et
al
walsh
et
al
includ
wm
spare
pansiot
et
al
pham
et
al
rodent
model
hyperoxia
schmitz
et
al
glutamateinduc
toxic
pansiot
et
al
indic
primarili
protect
effect
howev
due
concern
side
effect
adult
neonat
experiment
data
show
consist
benefit
present
appear
inadequ
support
recommend
clinic
test
cell
graft
stem
cell
precursor
import
avenu
therapi
demyelin
diseas
karimiabdolrezae
et
al
neonat
stroke
injuri
van
velthoven
et
al
goal
cell
replac
sher
et
al
attenu
damag
case
autoimmun
demyelin
mesenchym
stem
cell
transplant
lower
selfreact
reduc
damag
primarili
bystand
effect
immun
respons
payn
et
al
necessarili
involv
high
effici
cell
regener
circuit
restor
uccelli
mancardi
howev
intranas
mesenchym
stem
cell
deliveri
perinat
hypoxiaischemia
addit
shown
improv
regener
cortic
rewir
van
velthoven
et
al
differ
argu
need
better
understand
neural
cell
interact
lesion
environ
laterza
et
al
lisak
et
al
becom
wide
accept
stem
progenitor
cell
provid
immunomodulatori
neuroprotect
benefit
secret
growth
factor
chemokin
cytokin
stem
cell
regul
guidanc
molecul
function
stem
cell
secretom
therapeut
support
cellular
plastic
subject
recent
review
articl
cossetti
et
al
de
feo
et
al
drago
et
al
therapeut
potenti
use
stemprogenitor
cell
enhanc
genet
modif
transplant
human
umbil
mesenchym
stromal
cell
genet
modifi
express
see
section
growth
factor
promot
greater
myelin
spare
function
recoveri
compar
unmodifi
cell
rat
spinal
cord
compress
injuri
model
shang
et
al
intercellular
autocrin
signal
interact
form
underli
basi
repair
mechan
neurotroph
factor
brainderiv
neurotroph
factor
bdnf
test
treatment
cell
surviv
axon
growth
injuri
jain
et
al
lopatina
et
al
shu
et
al
rel
fewer
report
wm
regener
pharmacolog
intervent
includ
growth
factor
adult
neonat
injuri
model
address
pharmacolog
treatment
option
wm
injuri
perform
survey
report
describ
pharmacolog
signal
modul
demonstr
effect
neonat
adult
model
wm
injuri
studi
describ
section
summar
tabl
gener
employ
deliveri
pharmacolog
agent
either
system
administr
direct
inject
brain
tissu
ventricl
use
stereotax
method
understand
addit
neuroprotect
effect
agent
also
includ
summari
applic
report
pharmacolog
agent
brain
injuri
model
analysi
wm
ol
primari
object
studi
tabl
frequent
involv
disrupt
axon
axon
function
lead
excess
neurotransmitt
signal
axon
transport
mechan
impair
bakiri
et
al
varieti
neurotransmitt
receptor
express
oligodendrocyt
progenitor
butt
butt
et
al
adenosin
metabotrop
receptor
field
burnstock
nmda
de
bias
et
al
li
et
al
ampa
zonouzi
et
al
receptor
express
opc
glutam
receptor
activ
known
inhibit
opc
prolifer
lineag
progress
vitro
gallo
et
al
yuan
et
al
induc
cellular
toxic
opc
liu
et
al
injuri
model
excitotox
due
elev
glutam
atp
caus
structur
function
damag
wm
sustain
activ
atp
ampa
kainat
nmda
glutam
receptor
caus
ol
death
myelin
destruct
mitochondri
calcium
influx
matut
tang
xing
oligodendroglia
express
purinerg
receptor
serv
mediat
axooligodendrogli
commun
myelin
howev
eae
mechan
involv
atp
excitotox
mitig
receptor
blockad
matut
et
al
addit
direct
receptormedi
death
ol
damag
atp
signal
glial
purinerg
receptor
involv
neuroinflammatori
cascad
subsequ
exacerb
degener
matut
et
al
intracerebr
nmda
inject
corpu
callosum
neonat
gener
wm
lesion
excitotox
espinosajeffrey
et
al
perinat
injuri
adult
inflammatori
demyelin
model
shown
benefit
block
receptor
nbqx
ampa
receptor
antagonist
protect
neonat
mous
model
hypoxiaischemiamedi
wm
loss
follett
et
al
follett
et
al
shen
et
al
eae
demyelin
kanwar
et
al
pitt
et
al
improv
clinic
score
observ
chronic
eae
use
brilliant
blue
g
block
receptor
matut
et
al
howev
perinat
ischemia
receptor
express
decreas
potenti
benefit
brilliant
blue
g
ischemia
model
unclear
studi
thu
indic
similar
benefit
age
group
nbqx
suggest
common
mechan
wm
damag
involv
ampa
receptormedi
excitotox
therapeut
target
egf
adult
wm
brain
injuri
model
includ
subventricular
zone
svz
region
brain
rich
multipot
adult
stem
cell
prolifer
differenti
migrat
egfr
cell
svz
adult
mice
reportedli
correspond
mostli
precursor
cell
transit
amplifi
c
cell
potenti
differenti
neuroblast
astrocyt
ol
doetsch
et
al
egfr
signal
found
essenti
promot
ol
develop
svz
demyelin
aguirr
gallo
aguirr
et
al
intranas
heparin
bind
egf
administ
adult
mous
model
lysolecithcininduc
focal
demyelin
corpu
callosum
increas
prolifer
svz
cell
migrat
demyelin
corpu
callosum
addit
egf
treatment
increas
percentag
divid
astrocyt
ol
lineag
cell
brdugfap
brdu
demyelin
lesion
compar
control
cantarella
et
al
consist
find
egf
treatment
found
increas
cnpase
cell
deriv
cell
type
c
precursor
svz
decreas
lesion
volum
gonzalez
perez
et
al
viral
induc
overexpress
egfr
wm
glial
progenitor
post
natal
day
rat
result
perpetu
prolifer
opc
inhibit
ol
matur
ivkov
et
al
contrast
intranas
heparin
bind
egf
treatment
immedi
perinat
chronic
hypoxia
mice
model
preterm
brain
injuri
increas
surviv
ol
cell
prolifer
differenti
ol
well
improv
function
recoveri
scafidi
et
al
demonstr
egf
promot
wm
oligodendrogenesi
inhibit
notch
activ
cell
hypoxia
reliev
hypoxiainduc
inhibit
ol
matur
scafidi
et
al
basic
fibroblast
growth
factor
upregul
spinal
cord
injuri
correspond
time
activ
opc
prolifer
tripathi
mctigu
zai
et
al
bfgf
perinat
adult
model
cn
injuri
promot
prolifer
progenitor
cell
known
inhibit
termin
differenti
ol
vivo
intraventricular
infus
bfgf
postnat
day
rat
hypox
ischemia
increas
cell
divis
svz
nestin
neun
cell
jinqiao
et
al
adult
rat
intracistern
inject
bfgf
report
improv
axon
sprout
function
recoveri
cerebr
infarct
kawamata
et
al
although
found
elong
ol
process
found
regul
myelin
protein
postmitot
matur
ol
fact
bfgf
deliv
cerebrospin
fluid
disrupt
development
myelin
neonat
caus
opc
accumul
eventu
demyelin
adult
butt
dinsdal
b
goddard
et
al
bfgf
inhibit
remyelin
genet
ablat
opc
improv
gener
ol
well
sensorimotor
coordin
chronic
cuprizon
demyelin
model
mierzwa
et
al
zhou
et
al
patholog
effect
high
bfgf
level
may
mediat
astrocyt
microglia
rais
bfgf
ventricular
cerebrospin
fluid
neonat
rat
led
astrogli
microgli
reactiv
goddard
et
al
despit
properti
neuroprotect
aguilar
et
al
kirschner
et
al
base
effect
glia
bfgf
consid
stemprogenitor
cell
activ
whose
downregul
benefit
wm
ol
recoveri
insulinlik
growth
factor
regul
surviv
ness
et
al
ness
et
al
prolifer
min
et
al
differenti
cell
ol
lineag
activ
mammalian
target
rapamycin
mtor
pathway
tyler
et
al
treatment
shown
benefici
adult
demyelin
model
overexpress
transgen
mice
demyelin
cuprizon
found
increas
ol
cell
surviv
increas
remyelin
rate
mason
et
al
intraventricular
infus
increas
cell
corpu
callosum
cuprizon
induc
demyelin
sabo
et
al
contrast
inject
adenovir
vector
increas
mrna
express
lysolethecininduc
demyelin
lesion
spinal
cord
month
age
rat
promot
remyelin
suggest
remyelin
cell
respons
improv
aris
directli
injuri
site
oleari
et
al
intraven
subcutan
treatment
acut
eae
rat
chronic
relaps
eae
mous
improv
clinic
score
decreas
inflammatori
lesion
li
et
al
liu
et
al
howev
subcutan
treatment
acut
phase
eae
transient
improv
clinic
score
myelin
earli
time
point
treatment
chronic
phase
effect
clinic
score
remyelin
cannella
et
al
vari
result
may
attribut
time
treatment
type
eae
model
presenc
igf
bind
protein
intraperiton
inject
administ
symptom
onset
adopt
transfer
murin
model
eae
provid
mild
protect
combin
igf
bind
protein
increas
diseas
sever
lovettrack
et
al
although
found
ol
associ
plaqu
multipl
sclerosi
presenc
igf
bind
protein
also
detect
potenti
inhibit
myelin
synthesi
thwart
therapeut
effort
addit
may
also
impact
astrocyt
respons
injuri
studi
astrocyt
cultur
beta
adrenerg
receptor
knockout
mice
suggest
regul
depend
camp
signal
therefor
multipl
sclerosi
lesion
defici
observ
increas
potenti
risk
igfmedi
astrogliosi
found
promot
opc
differenti
matur
ol
subsequ
ol
surviv
neonat
model
inhibit
caspas
subsequ
protect
neonat
rat
prooligodendroblast
glutamatemedi
apoptosi
vitro
ness
et
al
substanti
vivo
intraventricular
inject
neonat
rat
hypoxia
model
postnat
day
decreas
caspas
caspas
activ
cerebr
cortex
associ
increas
phosphoryl
akt
nuclear
transloc
phosphoryl
bryw
et
al
furthermor
hypoxia
increas
opc
differenti
matur
ol
inhibit
promot
surviv
ol
lineag
cell
wood
et
al
treatment
hypoxiaischemia
also
found
improv
longterm
memori
cognit
behavior
zhong
et
al
activ
like
multipl
effect
ol
develop
promot
surviv
prolifer
opc
enhanc
ol
differenti
barr
et
al
cohen
et
al
kumar
et
al
protect
glutam
excitotox
kavanaugh
et
al
signal
high
affin
trkc
receptor
oligodendrogli
cell
kumar
de
velli
initi
translat
erk
signal
increas
synthesi
mbp
mag
mog
coelho
et
al
addit
prevent
oligodendrocyt
apoptosi
mechan
camprespons
element
bind
protein
creb
phosphoryl
promot
transloc
sphingosin
cytoplasm
membran
enhanc
activ
synthesi
upregul
johnson
et
al
saini
et
al
saini
et
al
oligodendrocyt
lineag
express
receptor
found
promot
matur
oligodendrocyt
surviv
progenitor
cell
process
retract
jaillard
et
al
implic
therapeut
potenti
regul
synthesi
demonstr
efficaci
fingolimod
act
agonist
receptor
phosphoryl
invivo
use
treatment
multipl
sclerosi
coelho
et
al
found
protect
oligodendrocyt
progenitor
cell
apoptosi
via
akt
pathway
inhibit
oligodendrocyt
differenti
howev
could
overcom
concomit
treatment
increas
oligodendrocyt
surviv
differenti
coelho
et
al
depend
abil
inhibit
apoptosi
yet
potenti
abrog
mediat
inhibit
oligodendrocyt
progenitor
differenti
suggest
either
distinct
sip
receptor
signal
import
two
distinct
pathway
may
promot
surviv
differenti
oligodendrocyt
progenitor
cell
contrast
fingolomod
treatment
eae
mous
model
activ
sonic
hedgehog
pathway
increas
opc
prolifer
differenti
zhang
et
al
activ
implic
cross
talk
also
pdgfaa
coelho
et
al
develop
brain
neuropeptid
found
induc
neonat
cerebrum
accompani
increas
mbp
express
hashimoto
et
al
remain
untest
neonat
brain
injuri
role
neonat
ol
protect
recoveri
present
unknown
earli
studi
shown
transplant
fibroblast
secret
neurotroh
factor
bdnf
demonstr
success
increas
oligodendrocyt
prolifer
myelin
spinal
cord
contus
rat
model
mctigu
et
al
demonstr
efficaci
neurotrophin
administr
traumat
injuri
sinc
specif
strategi
peptid
inject
viral
express
stem
cell
therapi
use
deliv
demyelin
lesion
includ
combinatori
intracrani
treatment
show
benefit
cuprizoneinduc
demyelin
adult
mice
pdgfaa
may
signal
aktpkb
inhibit
apoptosi
bfgf
pdgfa
may
also
serv
mitogen
stimul
prolifer
ol
lineag
cell
kumar
et
al
intracrani
inject
pdgfa
bfgf
increas
ol
lineag
prolifer
migrat
demyelin
region
increas
myelin
kumar
et
al
inject
directli
lysophosphatidylcholinedemyelin
corpu
callosum
adult
rat
decreas
lesion
volum
increas
mbp
cell
number
day
injuri
acut
phase
day
increas
number
gfap
cell
jean
et
al
suggest
direct
effect
oligodendrogli
lineag
altern
strategi
deliv
peptid
includ
implant
mesenchym
stem
cell
transfect
adenovir
vector
overexpress
ethidium
bromideinduc
demyelin
rat
spinal
cord
contrast
peptid
inject
acut
phase
demyelin
spinal
cord
lesion
jean
et
al
express
mesenchym
stem
cell
inject
day
postinjuri
found
improv
function
recoveri
increas
mbp
express
remyelin
lentivir
deliveri
anoth
deliveri
strategi
enhanc
myelin
axon
regener
spinal
cord
injuri
hou
et
al
thoma
et
al
differ
milieu
establish
variou
injuri
model
differ
speci
make
direct
comparison
treatment
paradigm
complic
howev
lentivir
deliveri
demonstr
efficaci
acut
chronic
phase
spinal
cord
injuri
albeit
differ
model
lentivir
deliveri
support
bridg
week
spinal
cord
injuri
mice
increas
express
nuclear
cell
indic
ol
lineag
gfap
astrocyt
yield
fold
increas
myelin
axon
extend
middl
bridg
compar
control
although
schwann
cell
contribut
increas
myelin
axon
thoma
et
al
model
demonstr
efficaci
use
lentivir
express
acut
phase
spinal
cord
injuri
transplant
lentivir
transduc
neural
progenitor
cell
secret
modifi
human
capabl
activ
trkb
trkc
receptor
differenti
astrocyt
oligodendrocyt
increas
volum
spare
myelin
chronic
phase
compress
spinal
cord
injuri
rat
transplant
week
injuri
kusano
et
al
lentivir
transduct
bone
marrowderiv
neural
stem
cell
anoth
therapeut
strategi
combin
benefit
nsc
transplant
product
easili
access
stem
cell
sourc
bone
marrowderiv
neural
stem
cell
transduc
increas
differenti
oligodendrocyt
myelin
decreas
astrogliosi
inflamm
inject
murin
eae
model
compar
bone
marrowderiv
neural
stem
cell
express
summari
signal
activ
erk
pathway
engag
crosstalk
signal
promot
oligodendrocyt
surviv
differenti
potenti
even
immunomodulatori
effect
direct
comparison
efficaci
injuri
model
made
due
intrins
differ
appar
chew
deboy
page
neuropharmacolog
author
manuscript
avail
pmc
novemb
benefit
deliveri
particularli
use
transduct
neural
stem
cell
combin
benefit
deriv
administr
neural
stem
cell
transplant
promot
increas
myelin
decreas
inflamm
bdnf
function
surviv
develop
neuron
glia
cn
chao
oper
primarili
regionspecif
express
trk
receptor
oligodendroglia
du
et
al
rat
spinal
cord
trkbexpress
cell
coexpress
indic
differenti
ol
small
opc
pool
also
show
trkb
immunoreact
suggest
function
growth
coulibali
et
al
ablat
trkb
receptor
oligodendrogli
lineag
disrupt
myelin
indirectli
increas
densiti
opc
wong
et
al
bdnf
promot
growth
opc
vondran
et
al
enhanc
ol
differenti
du
et
al
strong
therapeut
candid
wm
diseas
consist
low
level
bdnf
relapsingremit
multipl
sclerosi
azoulay
et
al
bdnf
found
critic
wm
mainten
demyelin
vondran
et
al
interestingli
antiinflammatori
agent
use
treatment
multipl
sclerosi
glatiram
acet
immunoregulatori
properti
also
enhanc
level
bdnf
vivo
aharoni
et
al
fingolimod
new
oral
drug
multipl
sclerosi
shown
attenu
neurotox
doi
et
al
improv
symptom
model
neurodegen
disord
fukumoto
et
al
rett
syndrom
deogracia
et
al
effect
associ
increas
level
bdnf
deogracia
et
al
doi
et
al
studi
indic
likelihood
approach
elev
endogen
bdnf
would
benefit
wm
patholog
eleg
studi
fulmer
et
al
found
bdnf
level
could
stimul
stereotax
inject
metabotrop
glutam
receptor
agonist
tran
acid
acpd
fulmer
et
al
effect
turn
mediat
metabotrop
glutam
receptor
astrocyt
oligodendrocyt
inject
acpd
corpu
callosum
week
cuprizon
intox
mice
increas
bdnf
mbp
mag
within
hour
gfapdirect
genet
ablat
bdnf
express
coinject
trkbfc
abolish
benefici
effect
acpd
vivo
indic
astrocyt
product
bdnf
respons
acpd
enhanc
myelin
recoveri
chemic
demyelin
fulmer
et
al
neonat
injuri
direct
intracerebroventricular
inject
bdnf
protect
neuron
caspasemedi
cell
death
neonat
hypoxicischemia
rat
model
cerebr
palsi
pathway
attenu
tissu
loss
memori
impair
almli
et
al
han
holtzman
treatment
intraperiton
humanin
increas
oligodendrogenesi
level
bdnf
neonat
hypoxiaischemia
model
accompani
axon
remyelin
reduc
neurolog
deficit
nuclear
receptor
like
thyroid
hormon
receptor
mediat
protect
thyroxin
thyroxin
regul
development
neurotrophin
express
develop
hippocampu
luess
et
al
prove
protect
wmi
bdnf
immatur
brain
hung
et
al
bdnftrkb
signal
attenu
follow
hypox
ischem
injuri
restor
new
trkb
agonist
permeabl
bloodbrain
barrier
jang
et
al
administ
ip
inject
decreas
astrocytosi
microgliosi
protect
preoligodendrocyt
apoptosi
hung
et
al
protect
effect
motor
perform
inhibit
trkbfc
block
activ
bdnf
hung
et
al
approach
acpd
await
test
neonat
wmi
addit
base
observ
would
interest
determin
whether
nonpeptid
treatment
found
mediat
neuroprotect
function
improv
also
regul
bdnf
express
signal
crosstalk
model
neonat
adult
wm
diseas
abil
ligand
thyroid
hormon
receptor
interact
mbp
promot
activ
express
farsetti
et
al
promot
ol
matur
fernandez
et
al
render
viabl
therapeut
strategi
adult
neonat
wm
damag
thyroid
hormon
show
therapeut
potenti
rang
adult
demyelin
model
triiodothyronin
prohormon
thyroxin
use
therapeut
agent
model
wm
damag
cuprizon
induc
upregul
thyroid
hormon
receptor
thr
alpha
thrb
treatment
preferenti
increas
express
thrb
suggest
thrb
respond
import
remyelin
process
franco
et
al
cuprizoneinduc
demyelin
rat
model
intranas
treatment
found
increas
mbp
cell
cerebr
cortex
silvestroff
et
al
subcutan
inject
decreas
number
progenitor
cell
nestin
increas
number
matur
ol
cell
increas
immunoreact
mbp
plp
corpu
callosum
franco
et
al
anoth
cuprizon
studi
treatment
restor
shh
svz
control
level
chang
shh
express
corpu
callosum
suggest
role
svz
cell
prolifer
migrat
matur
remyelin
process
franco
et
al
treatment
mice
also
shown
improv
clinic
score
decreas
abnorm
wm
appear
weight
imag
myelin
abnorm
well
increas
number
myelin
axon
prolifer
ol
progenitor
cell
recoveri
period
long
week
cuprizon
withdraw
chronic
cuprizon
demyelin
week
harsan
et
al
intraventricular
hemorrhag
caus
wm
damag
prematur
infant
found
decreas
activ
thyroid
hormon
deiodinas
increas
inactiv
thyroid
hormon
deiodinas
vose
et
al
intramuscular
inject
glycerolinduc
intraventricular
hemorrhag
rabbit
pup
found
increas
earli
ol
lineag
marker
express
increas
ol
prolifer
matur
well
increas
myelin
function
recoveri
vose
et
al
treatment
also
found
increas
densiti
myelin
ol
small
studi
use
preterm
human
infant
vose
et
al
administr
onset
symptom
chronic
demyelin
eae
model
lewi
da
rat
increas
pdgfa
r
mrna
rip
immunostain
mbp
rna
protein
express
spinal
cord
type
rat
decreas
sever
relaps
lewi
da
rat
fernandez
et
al
subcutan
inject
da
rat
eae
howev
found
improv
clinic
score
along
nerv
conduct
less
myelin
loss
greater
level
chew
wide
rang
effect
thyroid
hormon
concern
excess
may
caus
advers
side
effect
inspir
therapeut
strategi
specif
agonist
mice
increas
number
cell
protein
express
mbp
cnp
mag
corpu
callosum
occipit
cortex
optic
nerv
baxi
et
al
yet
test
injuri
model
well
establish
retino
acid
like
thyroid
hormon
promot
differenti
ol
progenitor
cell
mbp
gene
express
barr
et
al
laeng
et
al
noll
miller
pombo
et
al
addit
promot
glutathion
synthesi
regul
glutam
exchang
indic
capac
protect
glutam
excitotox
crockett
et
al
properti
retino
acid
suggest
applic
remyelin
repair
cn
injuri
retino
acid
rxr
ligand
tran
retino
acid
activ
rar
retino
acid
tran
retino
acid
reduc
infarct
size
ischemia
model
choi
et
al
shen
et
al
clinic
evid
indic
protect
effect
sex
steroid
estrogen
progesteron
multipl
sclerosi
kipp
et
al
also
emerg
studi
varieti
cn
injuri
diseas
model
includ
demyelin
deutsch
et
al
progesteron
promot
neurogenesi
cerebr
cortex
hippocampu
brinton
et
al
wang
et
al
regul
opc
develop
myelin
format
schwann
cell
marinhussteg
et
al
schumach
et
al
neuroprotect
effect
progesteron
ischemia
traumat
brain
injuri
may
part
mediat
antiinflammatori
properti
habib
et
al
lei
et
al
abil
preserv
mitochondri
function
robertson
saraswati
respect
addit
inhibit
inflammatori
mediat
progesteron
found
influenc
ol
cell
respons
cn
injuri
pretreat
progesteron
improv
clinic
sign
eae
mice
increas
number
matur
ol
express
myelin
protein
plp
mbp
myelin
densiti
precursor
cell
garay
progesteron
treatment
also
reduc
amount
demyelin
caus
lysophosphatidylcholin
murin
spinal
cord
increas
precursor
matur
ol
cell
decreas
macrophagemicroglia
cell
marker
chew
neuropharmacolog
author
manuscript
avail
pmc
novemb
garay
et
al
progesteron
treatment
demyelin
model
caus
chemic
toxin
inflammatori
mediat
increas
precursor
cell
chronic
progesteron
treatment
day
spinal
cord
injuri
rat
decreas
prolifer
increas
cell
indic
ol
matur
contrast
acut
progesteron
treatment
day
increas
opc
prolifer
also
inhibit
astrocyt
microgliamacrophag
prolifer
labombarda
et
al
neonat
hypoxiaischemia
ip
inject
progesteron
given
prior
hypoxia
led
reduc
neuron
apoptosi
brain
damag
protect
function
progesteron
model
divers
li
et
al
wang
et
al
may
involv
activ
inhibit
effect
progesteron
function
opc
neonat
wm
injuri
howev
remain
describ
futur
studi
transferrin
iron
transport
protein
express
develop
oligodendrogli
cell
connor
fine
promot
differenti
opc
stimul
express
gene
involv
myelinogenesi
ol
membran
format
escobar
cabrera
et
al
escobar
cabrera
et
al
escobar
cabrera
et
al
action
apotransferrin
shown
target
cytoskeleton
involv
tyrosin
kinas
protein
kinas
c
calciumcalmodulin
kinas
marta
et
al
ligand
transferrin
receptor
stimul
fyn
kinas
subsequ
phosphoryl
receptor
intern
activ
akt
cultur
oligodendrogli
cell
perez
et
al
thu
signal
pathway
import
myelin
format
guardioladiaz
et
al
ishii
et
al
interestingli
recent
found
thyroid
hormon
statu
determin
transferrin
express
neonat
rat
ie
hypothyroid
rat
show
decreas
transferrin
express
less
matur
myelin
phenotyp
hyperthyroid
anim
show
upregul
transferrin
myelin
marziali
et
al
apotransferrin
administr
unabl
rescu
hypothyroid
state
studi
marziali
et
al
hypomyelin
induc
thyroid
defici
allevi
earlier
studi
intracrani
inject
apotransferrin
postnat
age
day
badaracco
et
al
differ
efficaci
clear
answer
may
lie
mechan
regul
contribut
transferrin
effect
thyroid
hormon
euthyroid
injuri
model
apotransferrin
shown
effect
mitig
wm
damag
intranas
apotransferrin
treatment
neonat
mous
model
hypoxiaischemia
decreas
wm
damag
reduc
astrogliosi
increas
opc
prolifer
ol
surviv
improv
function
recoveri
guardia
clausi
et
al
combin
transferrin
effect
reduc
nmdainduc
excitotox
injuri
enhanc
regener
neonat
brain
espinosajeffrey
et
al
ms
tissu
found
ironrich
deposit
gray
matter
vicin
lesion
low
iron
normalappear
wm
remain
low
remyelin
plaqu
hametn
et
al
consist
notion
iron
deplet
ms
apotransferrin
found
effect
adult
model
demyelin
rat
chew
lysolecithin
demyelin
model
apotransferrin
inject
increas
mag
protein
express
remyelin
like
mediat
activ
notch
aparicio
et
al
apotransferrin
also
reduc
damag
eae
decreas
cell
product
saksida
et
al
acceler
remyelin
cuprizon
withdraw
adamo
et
al
thought
dysregul
ratio
free
bound
iron
local
intercellular
shuttl
impact
balanc
ironmedi
toxic
irondepend
remyelin
therefor
iron
shuttl
protein
like
transferrin
import
consider
therapi
stephenson
et
al
morphogenstissu
regener
like
develop
involv
process
shape
tissu
organ
format
signal
mechan
orchestr
morphogenesi
develop
also
import
modul
cell
growth
surviv
migrat
matur
remodel
wm
patholog
express
mani
morphogen
signal
sonic
hedgehog
shh
wntwingless
bone
morphogenet
protein
bmp
notch
shown
regul
anim
model
wm
injuri
pharmacolog
modul
alter
cours
wm
damag
hedgehog
famili
secret
protein
compris
sonic
shh
indian
ihh
desert
dhh
ligand
bind
patch
receptor
caus
subsequ
derepress
smoothen
lead
transduct
posit
signal
activ
gli
transcript
factor
ingham
mcmahon
muron
et
al
smoothen
activ
modul
pharmacolog
small
molecul
compound
cyclopamin
purmorphamin
smoothen
agonist
sag
sinc
initi
discoveri
sonic
hedgehog
despit
extens
character
function
induc
ventral
brain
structur
ol
cerebellum
kiecker
lumsden
lu
et
al
role
regener
adult
brain
begin
reveal
adult
brain
sonic
hedgehog
maintain
neural
stem
cell
neurogen
zone
machold
et
al
promot
precursor
cell
prolifer
lai
et
al
modul
migrat
precursor
zone
angot
et
al
sonic
hedgehog
induc
follow
brain
injuri
demyelin
amankulor
et
al
wang
et
al
inhibit
cyclopamin
inject
later
ventricl
aggrav
ischem
brain
damag
ji
et
al
numer
studi
shown
signific
benefit
enhanc
hedgehog
signal
brain
injuri
model
inde
addit
neural
cell
regener
sonic
hedgehog
promot
protect
ischem
damag
enhanc
angiogenesi
provid
resist
oxid
stress
maintain
immun
quiescenc
defend
integr
blood
brain
barrier
alvarez
et
al
inject
recombin
sonic
hedgehog
demyelin
adult
rat
spinal
cord
increas
prolifer
neural
precursor
cell
bambakidi
et
al
spinal
cord
contus
inject
shh
also
increas
cell
prolifer
transplant
opc
protect
wm
improv
axon
conduct
spinal
cord
function
bambakidi
miller
ischem
stroke
intrathec
administr
shh
improv
behavior
function
stimul
neural
precursor
prolifer
subventricular
zone
bambakidi
onwuzulik
consist
find
spinal
cord
injuri
lentivir
express
sonic
hedgehog
increas
myelin
ol
schwann
cell
respect
thoma
et
al
smoothen
agonist
purmorphamin
found
neuroprotect
model
ischem
brain
injuri
chechneva
et
al
sonic
hedgehog
regen
neuroprotect
lysolecithin
focal
demyelin
paradigm
shh
peptid
antagonist
hedgehog
interact
protein
hhip
express
adenoviru
vector
ferent
et
al
latter
studi
unknown
whether
canon
noncanon
hedgehog
signal
mediat
benefici
effect
hedgehog
regener
protect
glucocorticoid
commonli
use
preand
postnat
prevent
treat
lung
cardiovascular
diseas
lifethreaten
condit
associ
preterm
birth
crowther
et
al
miracl
et
al
howev
use
immunosuppress
steroid
dexamethason
mineralocorticoid
report
show
side
effect
well
impair
neurodevelop
halliday
et
al
anim
studi
shown
glucocorticoid
especi
repeat
administr
dexamethason
advers
affect
myelin
develop
brain
zia
et
al
despit
mix
report
improv
myelin
model
lipopolysaccharideinduc
perinat
brain
injuri
pang
et
al
wide
accept
risk
cerebellar
wm
damag
glucocorticoid
critic
period
brain
develop
may
outweigh
benefit
immunosuppress
addit
wellestablish
cerebellar
neuron
chang
dexamethason
recent
studi
describ
degen
apoptot
morpholog
chang
opc
loss
preol
lead
hypomyelin
kim
et
al
fact
high
subleth
glucocorticoidprenisolon
dose
use
anim
model
perinat
cerebellar
injuri
aden
et
al
noguchi
et
al
noguchi
et
al
relev
cerebellar
damag
prematur
infant
bodenstein
johnsen
volp
hedgehog
signal
critic
cerebellar
develop
dahman
ruiz
altaba
wechslerreya
scott
neonat
brain
system
administr
smoothen
analog
sag
transgen
smoothen
activ
result
improv
granul
neuron
gener
cerebellar
granul
neuron
progenitor
prolifer
glucocorticoid
injuri
model
chronic
glucocorticoid
treatment
first
postnat
week
inhibit
cerebellar
growth
hein
et
al
antagon
glucocorticoid
effect
mediat
induct
dehydrogenas
type
holm
et
al
smoothen
activ
hein
et
al
hein
rowitch
howev
present
unknown
whether
similar
approach
sag
would
attenu
wm
chang
develop
corpu
callosum
follow
perinat
hypox
injuri
although
caution
warrant
due
document
effect
hh
tumorigenesi
gulino
et
al
surpris
decreas
function
outcom
stem
cell
therapi
hypoxiaischemia
van
velthoven
et
al
like
hedgehog
wnt
signal
pathway
compris
famili
secret
ligand
activ
canon
noncanon
signal
cascad
regul
divers
cellular
function
neural
cell
develop
canon
signal
mediat
betacatenin
noncanon
wnt
signal
involv
betacateninindepend
pathway
planar
cell
polar
ror
receptor
gao
chen
van
amerongen
canon
wnt
signal
implic
neurogenesi
coylerink
et
al
neuron
cell
surviv
inject
express
plasmid
chew
later
ventricl
increas
strokeinduc
striatal
neurogenesi
adult
brain
activ
betacatenin
signal
lei
et
al
howev
emerg
role
betacatenin
express
opc
develop
injuri
appear
complex
betacatenin
opc
mediat
glial
scar
inhibit
axon
regener
traumat
brain
injuri
rodriguez
et
al
canon
wntbetacatenin
previous
identifi
signal
promot
stem
progenitor
cell
prolifer
kalani
et
al
inhibit
opc
develop
feigenson
et
al
shimizu
et
al
wnt
inhibit
tankyras
inhibitor
improv
remyelin
focal
wm
injuri
well
neonat
cerebellar
slice
follow
hypoxia
injuri
fanci
et
al
support
inhibitori
function
betacatenin
opc
matur
addit
elev
wnt
signal
also
found
neonat
wm
injuri
fanci
et
al
current
studi
indic
howev
effect
canon
wnt
signal
develop
ol
lineag
simpl
previous
thought
unexpect
posit
regulatori
function
opc
format
well
matur
recent
demonstr
vivo
genet
ablat
dai
et
al
lithium
chlorid
activ
betacatenin
alreadi
use
treat
neurolog
diseas
bipolar
mood
disord
chuang
chuang
base
antiapoptot
effect
beural
jope
recent
found
promot
express
myelin
gene
ol
cultur
meffr
et
al
note
effect
licl
betacatenin
meffr
et
al
termin
ol
differenti
ident
specif
involv
aktcreb
activ
lithium
overcom
inhibitori
effect
wnt
termin
opc
differenti
azim
butt
licl
effect
promot
protect
eae
remyelin
sciatic
nerv
de
sarno
et
al
makoukji
et
al
also
evid
neuroprotect
effect
wntbetacatenin
neonat
brain
lithium
chlorid
attenu
neuron
damag
neonat
hypoxiaischemia
shin
et
al
use
revers
glucocorticoidinduc
apoptosi
develop
cerebellum
cabrera
et
al
given
neonat
wm
injuri
found
associ
elev
wnt
signal
fanci
et
al
without
studi
examin
regen
effect
independ
antiinflammatori
properti
would
difficult
predict
outcom
pharmacolog
wntbetacatenin
modul
ol
develop
neonat
brain
injuri
bone
morphogenet
protein
origin
identifi
function
bone
growth
belong
transform
growth
factorbeta
famili
secret
protein
direct
pattern
multipl
organ
system
includ
specif
neuron
glial
cell
earli
nervou
system
traumat
injuri
adult
brain
spinal
cord
upregul
express
multipl
bmp
protein
antagonist
noggin
hampton
et
al
dysregul
express
bmp
mausnerfainberg
antagonist
noggin
urshanski
et
al
follistatin
urshanski
et
al
also
report
relapsingremit
multipl
sclerosi
bmp
may
neuroprotect
neuroregen
properti
cox
et
al
yabe
et
al
mani
studi
describ
benefici
effect
exogen
treatment
ip
inject
intracerebr
administr
lin
et
al
perid
et
al
wang
et
al
attenu
chew
deboy
page
neuropharmacolog
author
manuscript
avail
pmc
novemb
damag
strokeischemia
anim
model
interestingli
retino
acid
allevi
damag
transient
focal
ischemia
model
shen
et
al
howev
elev
demyelin
spinal
cord
lesion
mediat
gliotic
respons
astrocyt
fuller
et
al
phenomenon
associ
persist
demyelin
anderson
et
al
skripuletz
et
al
known
inhibit
ol
differenti
nicolay
et
al
wang
et
al
upregul
lesion
corpu
callosum
cuprizon
demyelin
cate
et
al
inhibit
intraventricular
infus
noggin
cuprizon
challeng
cate
et
al
infus
chordin
lysolecithin
demyelin
increas
gener
oligodendroglia
svz
jablonska
et
al
model
ischem
brain
injuri
noggin
infus
decreas
glial
scar
also
shown
induc
altern
activ
microglia
ie
demonstr
addit
function
support
tissu
repair
remodel
shin
et
al
treatment
development
brain
injuri
recombin
noggin
also
produc
posit
result
regard
oligodendroglia
intraventricular
hemorrhag
injuri
immatur
brain
dummula
et
al
lead
loss
ol
cell
death
reduc
prolifer
matur
opc
intraventricular
infus
noggin
result
reduc
gliosi
restor
develop
enhanc
opc
matur
within
first
two
postnat
week
effect
noggin
infus
adult
develop
brain
support
transgen
overexpress
noggin
observ
smaller
infarct
volum
increas
opc
respons
motor
recoveri
follow
ischemia
samanta
et
al
perinat
hypoxiaischemia
dizon
et
al
consist
find
recombin
noggin
adult
cate
et
al
increas
popul
cell
noggin
transgen
mous
aris
prolifer
instead
nascent
induct
precursor
cell
dizon
et
al
notch
import
development
pathway
neural
stem
cell
regul
neural
precursor
fate
determin
develop
brain
plastic
louvi
artavanistsakona
yoon
gaiano
notch
signal
initi
direct
interact
cell
surfac
notch
receptor
cognat
ligand
delta
express
adjac
cell
caus
notch
receptor
undergo
two
proteolyt
cleavag
event
mediat
sequenti
adam
metalloproteas
gammasecretas
latter
releas
intracellular
notch
receptor
intracellular
domain
nicd
signal
receiv
cell
allow
nicd
transloc
nucleu
activ
target
gene
transcript
coactiv
csl
complex
andersson
et
al
notch
signal
activ
gliogen
respons
adult
subventricular
zone
traumat
brain
injuri
givogri
et
al
abnorm
notch
express
level
document
diseas
includ
syndrom
alzheim
diseas
fischer
et
al
veeraraghavalu
et
al
multipl
sclerosi
john
et
al
notch
pathway
inhibit
ol
differenti
wang
et
al
well
myelin
givogri
et
al
despit
contribut
ligand
favor
ol
gener
matur
outcom
ablat
opc
result
prematur
ol
differenti
indic
net
inhibitori
function
genoud
et
al
although
express
ethidiumbromideinduc
demyelin
lesion
trigemin
tract
stidworthi
et
al
chew
deboy
page
neuropharmacolog
author
manuscript
avail
pmc
novemb
surprisingli
oligodendroglialspecif
ablat
notch
show
rate
remyelin
cuprizon
alter
stidworthi
et
al
indic
ratedetermin
step
interestingli
treatment
benefit
remyelin
apotransferrin
aparicio
et
al
instead
activ
notch
signal
promot
remyelin
gamma
secretas
inhibitor
dapt
abolish
apotransferininduc
promyelin
effect
indic
posit
regulatori
role
notch
remyelin
focal
demyelin
paradigm
use
lysolecithin
nonetheless
widespread
express
notch
remain
import
determin
outcom
wm
patholog
reactiv
astrocyt
upregul
wm
lesion
activ
notch
signal
via
induc
inhibit
prevent
notch
signal
restor
remyelin
opc
earlier
studi
analyz
effect
pharmacolog
inhibitor
gammasecretas
administ
postimmun
intraventricular
inject
eae
demyelin
model
jurynczyk
et
al
rate
recoveri
assess
clinic
score
depend
dose
appar
within
day
treatment
accompani
enhanc
myelin
repair
base
histopatholog
ol
marker
reduc
inflammatori
respons
significantli
less
nerv
fiber
damag
wallerian
degener
without
remark
glial
scar
jurynczyk
et
al
effect
nicd
level
analyz
cultur
ol
ex
vivo
confirm
activ
notch
activ
notch
signal
critic
function
immun
cell
includ
differenti
helper
cell
respons
pretreat
gamma
secretas
inhibitor
reduc
clinic
symptom
anoth
studi
eae
minter
et
al
helper
polar
subset
inhibit
along
autoimmun
protect
effect
notch
attenu
specif
ol
neuron
matur
hippocampu
also
enhanc
intraventricular
administr
gammasecretas
inhibitor
ischem
injuri
oya
et
al
neonat
brain
injuri
recent
evid
implic
notch
hypoxiainduc
inflammatori
damag
yao
et
al
pretreat
ip
inject
gamma
secretas
inhibitor
dapt
hypoxia
rat
prevent
nicd
express
cerebr
microglia
concomit
nfkappab
activ
primari
cultur
microglia
induct
nicd
associ
nfkappab
activ
express
cytokin
nfkb
cytokin
express
block
dapt
yao
et
al
studi
need
determin
effect
dapt
attenu
neural
cell
damag
neonat
model
thymosin
small
thymusderiv
actinbind
peptid
widerang
pleiotropi
repair
multipl
tissu
type
treadwel
et
al
releas
cell
injuri
reduc
damag
limit
cell
apoptosi
inflamm
addit
control
scar
format
promot
cell
migrat
bind
gactin
monom
progenitor
cell
differenti
subsequ
angiogenesi
tissu
remodel
wound
heal
shown
neuroprotect
number
adult
rodent
injuri
model
includ
embol
stroke
morri
et
al
traumat
brain
contus
injuri
xiong
et
al
eae
demyelin
chew
deboy
page
neuropharmacolog
author
manuscript
avail
pmc
novemb
zhang
et
al
thymosin
administ
intraperiton
postinjuri
morri
et
al
xiong
et
al
simultan
plpimmun
eae
zhang
et
al
show
improv
clinic
score
model
cellular
level
treatment
thymosin
stimul
opc
prolifer
promot
matur
cnp
ol
detect
brdu
label
increas
oligodendrogenesi
observ
svz
wm
also
hippocampu
thymosin
stimul
opc
develop
modul
kinas
signal
chew
et
al
fragoso
et
al
hain
et
al
santra
et
al
possibl
mediat
upregul
santra
et
al
efficaci
neonat
brain
injuri
howev
remain
unknown
promis
evid
clinic
trial
treatment
variou
wound
find
upcom
experi
appli
thymosin
development
wm
injuri
model
doubt
eagerli
await
divers
array
injuri
model
produc
wm
damag
experiment
rodent
intrins
differ
model
may
impact
observ
efficaci
pharmacolog
agent
age
experiment
anim
affect
level
inhibitori
factor
wm
prolif
respons
germin
zone
gener
neural
precursor
popul
wm
eg
svz
therebi
modul
remyelin
repair
mcginn
et
al
shen
et
al
tang
et
al
furthermor
deliveri
rout
dose
regimen
well
intrins
differ
amongst
eae
model
also
sourc
variabl
mani
pharmacolog
treatment
target
growth
surviv
andor
matur
precursor
cell
opc
egf
igf
bdnf
thyroid
hormon
apotransferrin
show
benefici
effect
neonat
adult
brain
injuri
demyelin
group
peptid
factor
particular
present
great
promis
much
work
done
evalu
efficaci
igf
egf
bfgf
treat
wm
damag
reveal
potenti
also
consider
barrier
effect
treatment
igf
treatment
neonat
injuri
model
provid
one
consist
effect
promot
oligodendrocyt
differenti
surviv
action
howev
depend
activ
recruit
endogen
cell
migrat
germin
region
subventricular
zone
injuri
site
effect
egf
demyelin
adult
rodent
model
also
due
larg
part
prolifer
migrat
multipot
adult
stem
cell
subventricular
zone
site
injuri
similar
igf
egf
administr
shown
promot
ol
differenti
surviv
neonat
wm
injuri
model
although
bfgf
neuroprotect
effect
promot
prolifer
progenitor
stem
cell
report
inhibit
termin
differenti
oligodendrocyt
decreas
remyelin
adult
injuri
model
disrupt
myelin
neonat
model
make
bfgf
less
favor
wm
therapeut
strategi
bdnf
stand
among
peptid
neurotrophin
consist
promot
oligodendrocyt
differenti
surviv
across
variou
injuri
model
potenti
tempor
spatial
distribut
trkc
trkb
receptor
develop
injuri
well
differenti
express
trophic
factor
critic
oligodendrocyt
surviv
differenti
myelin
import
trophic
factor
whose
chew
individu
effect
overlap
evid
numer
adult
neonat
injuri
model
benefit
bdnf
treatment
possibl
addit
advantag
neurotrophin
aris
part
abil
modul
patholog
effect
inflamm
provid
neuroprotect
jiang
et
al
yang
et
al
furthermor
advanc
deliveri
option
gene
modif
stem
cell
transplant
provid
even
opportun
trophic
factor
incorpor
treatment
paradigm
wm
diseas
notic
neonat
wm
studi
show
effect
bdnf
thymosin
rarrxr
agonist
report
although
reason
unclear
risk
teratogen
retinoid
deriv
may
well
limit
use
development
brain
injuri
nonetheless
discuss
regard
potenti
therapeut
benefit
autism
spectrum
disord
ebstein
et
al
indic
ongo
interest
understand
uterin
condit
alter
isoform
level
balanc
fetu
goldberg
sensit
develop
brain
retinoid
effect
impact
neural
cell
matur
function
plastic
although
neonat
adult
patholog
often
consid
isol
relationship
neonat
event
adult
risk
also
recogn
neonat
exposur
dexamethason
increas
suscept
autoimmun
diseas
adult
bakker
et
al
longterm
neurolog
outcom
neonat
also
determin
extent
infant
immatur
multipl
matern
influenc
knuesel
et
al
often
complic
therapeut
strategi
increas
understand
etiolog
base
wm
patholog
facilit
search
safe
effect
minim
invas
form
intervent
taken
togeth
studi
indic
pharmacolog
approach
biofactor
small
molecul
modul
constitut
viabl
avenu
therapi
requir
investig
due
consider
togeth
cellbas
procedur
order
provid
favor
condit
neuroprotect
immunomodul
cellular
regener
